Evotec (EVO) details 9M 2025 results and strategy progress in 6-K filing

Rhea-AI Filing Summary

Evotec SE furnished a report for investors summarizing that it has released its financial results and business updates for the first nine months of 2025. The company states that these details are contained in a press release attached as Exhibit 99.1 to this report.

The exhibit is titled “Evotec SE reports 9M 2025 results: Continued strong execution on strategic priorities,” indicating that management views its progress on key strategic goals as ongoing. The report is signed by the Chief Financial Officer, Paul Hitchin.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of November, 2025

COMMISSION FILE NUMBER 001-34041

Evotec SE
(Translation of registrant’s name into English)

Essener Bogen 7

22419 Hamburg

Germany

Tel: +49 40 560810
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F: Form 20-F x Form 40-F ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

On November 5, 2025, Evotec SE (the “Company”) issued a press release announcing the Company’s financial results and business updates for the first nine months of 2025 attached hereto as Exhibit 99.1.

EXHIBIT INDEX

Exhibit		Description of Exhibit
99.1		Evotec SE reports 9M 2025 results: Continued strong execution on strategic priorities

SIGNATURE

Pursuant to the requirements, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Evotec SE
	By:	/s/ Paul Hitchin
		Name:	Paul Hitchin
		Title:	Chief Financial Officer

Date: November 5, 2025

FAQ

What does Evotec (EVO) report in its November 2025 Form 6-K?

Evotec’s November 2025 Form 6-K states that the company issued a press release with financial results and business updates for the first nine months of 2025, furnished as Exhibit 99.1. The filing itself mainly serves to formally transmit that press release.

Which period’s results are covered by Evotec’s (EVO) attached press release?

The attached press release covers Evotec’s financial results and business updates for the first nine months of 2025. This suggests a year-to-date update rather than a full-year or single-quarter report, giving investors an interim view of performance.

What is Exhibit 99.1 in Evotec’s (EVO) November 2025 Form 6-K?

Exhibit 99.1 is titled “Evotec SE reports 9M 2025 results: Continued strong execution on strategic priorities.” It contains detailed financial results and business updates for the first nine months of 2025, which are only referenced, not reproduced, in the main Form 6-K text.

Who signed Evotec’s (EVO) November 5, 2025 Form 6-K?

The Form 6-K was signed on behalf of Evotec by Paul Hitchin, the company’s Chief Financial Officer. His signature indicates he is the authorized officer attesting to the submission of the report and the attached exhibit on that date.

Does Evotec’s (EVO) Form 6-K include detailed financial figures for 9M 2025?

The Form 6-K itself does not provide detailed figures; it references a separate press release as Exhibit 99.1 for full financial results and business updates. Investors must review that exhibit to see specific numbers and performance metrics.

Under which annual report form does Evotec (EVO) file with the SEC?

Evotec indicates in this report that it files its annual reports with the SEC under Form 20-F. This classification confirms its status as a foreign private issuer using that framework for annual disclosure rather than the Form 40-F regime.